LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 1226

Search options

  1. Article: Wenxin Keli for the Treatment of Arrhythmia-Systems Pharmacology and

    Li, Xiaofeng / Tian, Gang / Xu, Liang / Sun, Lili / Tao, Rui / Zhang, Shaoqiang / Cong, Zidong / Deng, Fangjun / Chen, Jinhong / Yu, Yang / Du, Wuxun / Zhao, Hucheng

    Frontiers in pharmacology

    2021  Volume 12, Page(s) 704622

    Abstract: ... mechanisms of Wenxin Keli for arrhythmia treatment. Sixty-eight components identified ...

    Abstract This study employed a systems pharmacology approach to identify the active compounds and action mechanisms of Wenxin Keli for arrhythmia treatment. Sixty-eight components identified
    Language English
    Publishing date 2021-08-26
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2587355-6
    ISSN 1663-9812
    ISSN 1663-9812
    DOI 10.3389/fphar.2021.704622
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Efficacy and safety of Wenxin Keli combined with metoprolol tartrate in the treatment of premature ventricular contractions: A systematic review and meta-analysis.

    Huang, Ping / Luo, Yining / Chen, Jiaxue / Xu, Jingke / Shi, Yuanshu / Chen, Guoren / Ma, Ping

    Frontiers in cardiovascular medicine

    2022  Volume 9, Page(s) 952657

    Abstract: Background: Wenxin Keli (WXKL) has good clinical value in the treatment ... premature ventricular contractions (RR = 1.32, 95% CI: [1.24, 1.40], : Conclusion: This study found that Wenxin Keli combined ...

    Abstract Background: Wenxin Keli (WXKL) has good clinical value in the treatment of premature ventricular contractions, but there is insufficient evidence to support it. This study evaluates the efficacy and safety of WXKL combined with metoprolol tartrate in the treatment of ventricular premature beats (VPCs).
    Methods: We searched seven databases to identify randomized controlled trials (RCTs) for this study. Two reviewers independently screened and extracted the data. The Cochrane Manual criteria were used for methodological quality assessment. Meta-analyses were performed using Review Manager 5.4.1 software. Risk ratios (RR) were used for effect sizes for dichotomous data, demonstrated in effect sizes and 95% confidence intervals (CIs).
    Results: A total of 11 RCTs of WXKL combined with metoprolol tartrate in the treatment of premature ventricular contractions were included in this study. Meta-analysis showed that WXKL combined with metoprolol tartrate (treatment group) was more effective than metoprolol tartrate (control group) in improving premature ventricular contractions (RR = 1.32, 95% CI: [1.24, 1.40],
    Conclusion: This study found that Wenxin Keli combined with metoprolol tartrate in the treatment of premature ventricular contractions increased the efficacy of the drug, reduced the occurrence of adverse reactions, and reduced the severity of adverse reactions. Due to the quality limitations of the included studies, more high-quality RCTs are needed in the future to provide more evidence for longer-term analyses.
    Language English
    Publishing date 2022-07-29
    Publishing country Switzerland
    Document type Systematic Review
    ZDB-ID 2781496-8
    ISSN 2297-055X
    ISSN 2297-055X
    DOI 10.3389/fcvm.2022.952657
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Efficacy of Wenxin Keli Plus Amiodarone versus Amiodarone Monotherapy in Treating Recent-Onset Atrial Fibrillation.

    Zhang, Nixiao / Tse, Gary / Dahal, Shristi / Yang, Yajuan / Gong, Mengqi / Chan, Calista Zhuo Yi / Liu, Enzhao / Xu, Gang / Letsas, Konstantinos P / Korantzopoulos, Panagiotis / Li, Guangping / Liu, Tong

    Cardiology research and practice

    2018  Volume 2018, Page(s) 6047271

    Abstract: ... prolonged periods. Wenxin Keli (WXKL), a Chinese herb extract, has been shown to be effective in atrial ...

    Abstract Background: Use of amiodarone (AMIO) in atrial fibrillation (AF) has significant side effects over prolonged periods. Wenxin Keli (WXKL), a Chinese herb extract, has been shown to be effective in atrial-selective inhibiting peak
    Methods: A total of 41 patients (71 ± 12 years, 44% male) with recent-onset (<48 h) AF eligible for conversion were randomized to receive either intravenous amiodarone (loading dose 5 mg/kg in 1 hour followed by 50 mg/h;
    Results: Conversion rate at 24 hours was of no difference between the two groups (75.0% vs. 81.0%,
    Conclusion: Administration of amiodarone plus WXKL for recent-onset AF conversion was safe and effective, with faster sinus rhythm restoration compared with amiodarone alone.
    Language English
    Publishing date 2018-12-04
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2506187-2
    ISSN 2090-0597 ; 2090-8016
    ISSN (online) 2090-0597
    ISSN 2090-8016
    DOI 10.1155/2018/6047271
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Systematic Qualitative and Quantitative Analyses of Wenxin Granule via Ultra-High Performance Liquid Chromatography Coupled with Ion Mobility Quadrupole Time-of-Flight Mass Spectrometry and Triple Quadrupole-Linear Ion Trap Mass Spectrometry.

    Mi, Yueguang / Hu, Wandi / Li, Weiwei / Wan, Shiyu / Xu, Xiaoyan / Liu, Meiyu / Wang, Hongda / Mei, Quanxi / Chen, Qinhua / Yang, Yang / Chen, Boxue / Jiang, Meiting / Li, Xue / Yang, Wenzhi / Guo, Dean

    Molecules (Basel, Switzerland)

    2022  Volume 27, Issue 11

    Abstract: Wenxin granule (WXG) is a popular traditional Chinese medicine (TCM) preparation for the treatment ...

    Abstract Wenxin granule (WXG) is a popular traditional Chinese medicine (TCM) preparation for the treatment of arrhythmia disease. Potent analytical technologies are needed to elucidate its chemical composition and assess the quality differences among multibatch samples. In this work, both a multicomponent characterization and quantitative assay of WXG were conducted using two liquid chromatography-mass spectrometry (LC-MS) approaches. An ultra-high performance liquid chromatography-ion mobility quadrupole time-of-flight mass spectrometry (UHPLC/IM-QTOF-MS) approach combined with intelligent peak annotation workflows was developed to characterize the multicomponents of WXG. A hybrid scan approach enabling alternative data-independent and data-dependent acquisitions was established. We characterized 205 components, including 92 ginsenosides, 53 steroidal saponins, 14 alkaloids, and 46 others. Moreover, an optimized scheduled multiple reaction monitoring (sMRM) method was elaborated, targeting 24 compounds of WXG via ultra-high performance liquid chromatography-triple quadrupole linear ion trap mass spectrometry (UHPLC/QTrap-MS), which was validated based on its selectivity, precision, stability, repeatability, linearity, sensitivity, recovery, and matrix effect. By applying this method to 27 batches of WXG samples, the content variations of multiple markers from Notoginseng Radix et Rhizoma (21) and Codonopsis Radix (3) were depicted. Conclusively, we achieved the comprehensive multicomponent characterization and holistic quality assessment of WXG by targeting the non-volatile components.
    MeSH term(s) Chromatography, High Pressure Liquid/methods ; Chromatography, Liquid ; Drugs, Chinese Herbal ; Ginsenosides/analysis ; Mass Spectrometry/methods
    Chemical Substances Drugs, Chinese Herbal ; Ginsenosides ; wenxin keli
    Language English
    Publishing date 2022-06-06
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 1413402-0
    ISSN 1420-3049 ; 1431-5165 ; 1420-3049
    ISSN (online) 1420-3049
    ISSN 1431-5165 ; 1420-3049
    DOI 10.3390/molecules27113647
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Systematic Qualitative and Quantitative Analyses of Wenxin Granule via Ultra-High Performance Liquid Chromatography Coupled with Ion Mobility Quadrupole Time-of-Flight Mass Spectrometry and Triple Quadrupole–Linear Ion Trap Mass Spectrometry

    Yueguang Mi / Wandi Hu / Weiwei Li / Shiyu Wan / Xiaoyan Xu / Meiyu Liu / Hongda Wang / Quanxi Mei / Qinhua Chen / Yang Yang / Boxue Chen / Meiting Jiang / Xue Li / Wenzhi Yang / Dean Guo

    Molecules, Vol 27, Iss 3647, p

    2022  Volume 3647

    Abstract: Wenxin granule (WXG) is a popular traditional Chinese medicine (TCM) preparation for the treatment ...

    Abstract Wenxin granule (WXG) is a popular traditional Chinese medicine (TCM) preparation for the treatment of arrhythmia disease. Potent analytical technologies are needed to elucidate its chemical composition and assess the quality differences among multibatch samples. In this work, both a multicomponent characterization and quantitative assay of WXG were conducted using two liquid chromatography–mass spectrometry (LC-MS) approaches. An ultra-high performance liquid chromatography–ion mobility quadrupole time-of-flight mass spectrometry (UHPLC/IM-QTOF-MS) approach combined with intelligent peak annotation workflows was developed to characterize the multicomponents of WXG. A hybrid scan approach enabling alternative data-independent and data-dependent acquisitions was established. We characterized 205 components, including 92 ginsenosides, 53 steroidal saponins, 14 alkaloids, and 46 others. Moreover, an optimized scheduled multiple reaction monitoring (sMRM) method was elaborated, targeting 24 compounds of WXG via ultra-high performance liquid chromatography–triple quadrupole linear ion trap mass spectrometry (UHPLC/QTrap-MS), which was validated based on its selectivity, precision, stability, repeatability, linearity, sensitivity, recovery, and matrix effect. By applying this method to 27 batches of WXG samples, the content variations of multiple markers from Notoginseng Radix et Rhizoma (21) and Codonopsis Radix (3) were depicted. Conclusively, we achieved the comprehensive multicomponent characterization and holistic quality assessment of WXG by targeting the non-volatile components.
    Keywords Wenxin granule ; multicomponent characterization ; HDMS E -HDDDA ; UHPLC-sMRM ; quality evaluation ; Organic chemistry ; QD241-441
    Subject code 540 ; 621
    Language English
    Publishing date 2022-06-01T00:00:00Z
    Publisher MDPI AG
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  6. Article ; Online: The Efficacy and Safety of Wenxin Keli in Patients with Frequent Premature Ventricular Contractions

    Wei Hua / Run-Lin Gao / Bu-Chang Zhao / Jing Wang / Xu-Hua Chen / Chi Cai / Shu Zhang

    Chinese Medical Journal, Vol 128, Iss 19, Pp 2557-

    A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Trial

    2015  Volume 2564

    Abstract: ... the efficacy and safety of a traditional Chinese medicine Wenxin Keli for the treatment of frequent PVCs ... of 1:1 to receive Wenxin Keli or the placebo for 4 weeks. The primary and secondary endpoint was ... were observed between the Wenxin Keli group and the placebo group. A smaller number of PVCs was ...

    Abstract Background: Premature ventricular contractions (PVCs) are common in the general population, and frequent PVCs may result in the poor quality of life or even the damage of cardiac function. We examined the efficacy and safety of a traditional Chinese medicine Wenxin Keli for the treatment of frequent PVCs among a relatively large Chinese cohort. Methods: We performed a randomized, double-blind, placebo-controlled, parallel-group, multicenter trial. A total of 1200 eligible participants were randomly assigned in a ratio of 1:1 to receive Wenxin Keli or the placebo for 4 weeks. The primary and secondary endpoint was the change of PVC numbers and PVC-related symptoms after a 4-week treatment compared with baseline, respectively. In addition, vital signs, laboratory values, and electrocardiographic parameters were assessed in a safety analysis. Results: At the initial evaluation, no significant differences in the baseline characteristics were observed between the Wenxin Keli group and the placebo group. A smaller number of PVCs was observed after the 4-week treatment than at baseline, in both the Wenxin Keli group (5686 ± 5940 vs. 15,138 ± 7597 beats/d, P < 0.001) and the placebo group (10,592 ± 8009 vs. 14,529 ± 5929 beats/d, P < 0.001); moreover, the Wenxin Keli group demonstrated a significantli greater reduction in the frequency of PVCs than the placebo group (P < 0.001). In a full analysis set, patients in the Wenxin Keli group exhibited significantly higher total effective responses in the reduction of PVCs compared to those in the placebo group (83.8% vs. 43.5%,P < 0.001). The per-protocol analysis yielded similar results (83.0% vs. 39.3%,P < 0.001). Treatment with Wenxin Keli also demonstrated superior performance compared to the placebo with respect to PVC-related symptoms. No severe adverse effects attributable to Wenxin Keli were reported. Conclusions: Wenxin Keli treatment effectively reduced the overall number of PVCs and alleviated PVC-related symptoms in patients without structural heart ...
    Keywords Wenxin Keli ; Premature Ventricular Contractions ; Efficacy ; Safety ; Clinical Trial ; Medicine ; R
    Subject code 610
    Language English
    Publishing date 2015-01-01T00:00:00Z
    Publisher Wolters Kluwer
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  7. Article: The Efficacy and Safety of Wenxin Keli in Patients with Frequent Premature Ventricular Contractions: A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Trial.

    Hua, Wei / Gao, Run-Lin / Zhao, Bu-Chang / Wang, Jing / Chen, Xu-Hua / Cai, Chi / Zhang, Shu

    Chinese medical journal

    2015  Volume 128, Issue 19, Page(s) 2557–2564

    Abstract: ... the efficacy and safety of a traditional Chinese medicine Wenxin Keli for the treatment of frequent PVCs ... of 1:1 to receive Wenxin Keli or the placebo for 4 weeks. The primary and secondary endpoint was ... characteristics were observed between the Wenxin Keli group and the placebo group. A smaller number of PVCs was ...

    Abstract Background: Premature ventricular contractions (PVCs) are common in the general population, and frequent PVCs may result in the poor quality of life or even the damage of cardiac function. We examined the efficacy and safety of a traditional Chinese medicine Wenxin Keli for the treatment of frequent PVCs among a relatively large Chinese cohort.
    Methods: We performed a randomized, double-blind, placebo-controlled, parallel-group, multicenter trial. A total of 1200 eligible participants were randomly assigned in a ratio of 1:1 to receive Wenxin Keli or the placebo for 4 weeks. The primary and secondary endpoint was the change of PVC numbers and PVC-related symptoms after a 4-week treatment compared with baseline, respectively. In addition, vital signs, laboratory values, and electrocardiographic parameters were assessed in a safety analysis.
    Results: At the initial evaluation, no significant differences in the baseline characteristics were observed between the Wenxin Keli group and the placebo group. A smaller number of PVCs was observed after the 4-week treatment than at baseline, in both the Wenxin Keli group (5686 ± 5940 vs. 15,138 ± 7597 beats/d, P < 0.001) and the placebo group (10,592 ± 8009 vs. 14,529 ± 5929 beats/d, P < 0.001); moreover, the Wenxin Keli group demonstrated a significantli greater reduction in the frequency of PVCs than the placebo group (P < 0.001). In a full analysis set, patients in the Wenxin Keli group exhibited significantly higher total effective responses in the reduction of PVCs compared to those in the placebo group (83.8% vs. 43.5%,P < 0.001). The per-protocol analysis yielded similar results (83.0% vs. 39.3%,P < 0.001). Treatment with Wenxin Keli also demonstrated superior performance compared to the placebo with respect to PVC-related symptoms. No severe adverse effects attributable to Wenxin Keli were reported.
    Conclusions: Wenxin Keli treatment effectively reduced the overall number of PVCs and alleviated PVC-related symptoms in patients without structural heart diseases and had no severe side effects.
    MeSH term(s) Adult ; Aged ; Double-Blind Method ; Drugs, Chinese Herbal/adverse effects ; Drugs, Chinese Herbal/therapeutic use ; Female ; Humans ; Male ; Middle Aged ; Quality of Life ; Treatment Outcome ; Ventricular Premature Complexes/drug therapy
    Chemical Substances Drugs, Chinese Herbal ; wenxin keli
    Language English
    Publishing date 2015-10-05
    Publishing country China
    Document type Journal Article ; Multicenter Study ; Randomized Controlled Trial ; Research Support, Non-U.S. Gov't
    ZDB-ID 127089-8
    ISSN 0366-6999 ; 1002-0187
    ISSN 0366-6999 ; 1002-0187
    DOI 10.4103/0366-6999.166026
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Mechanistic insights into manganese oxide impacting the oxidation and transport of Cr(III) immobilized by nano-zero valent charged ion particles in water-saturated porous media.

    Sun, Wu / Xu, Nan / Jiang, Wenxin / Cheng, Gongbi

    Journal of hazardous materials

    2024  Volume 469, Page(s) 134050

    Abstract: The presence of manganese oxide ( ... ...

    Abstract The presence of manganese oxide (MnO
    Language English
    Publishing date 2024-03-16
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 1491302-1
    ISSN 1873-3336 ; 0304-3894
    ISSN (online) 1873-3336
    ISSN 0304-3894
    DOI 10.1016/j.jhazmat.2024.134050
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Morphological characteristics and phylogenetic evidence reveal two new species and the first report of

    Xu, Rong / Su, Wenxin / Wang, Yang / Tian, Shangqing / Li, Yu / Phukhamsakda, Chayanard

    MycoKeys

    2024  Volume 101, Page(s) 95–112

    Abstract: ... Two ... ...

    Abstract Two novel
    Language English
    Publishing date 2024-01-12
    Publishing country Bulgaria
    Document type Journal Article
    ZDB-ID 2630648-7
    ISSN 1314-4049 ; 1314-4049
    ISSN (online) 1314-4049
    ISSN 1314-4049
    DOI 10.3897/mycokeys.101.113040
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: Anti-

    Yan, Weifeng / Cui, Zhe / Li, Wenxin / An, Xin / Cheng, Xu / Wang, Sihong / Jin, Chunmei

    Die Pharmazie

    2024  Volume 78, Issue 11, Page(s) 225–230

    Abstract: New anti- ...

    Abstract New anti-
    MeSH term(s) Animals ; Mice ; Saponins/pharmacology ; Toxoplasma ; Panax ; Polysaccharides/pharmacology
    Chemical Substances Saponins ; Polysaccharides
    Language English
    Publishing date 2024-01-05
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 208793-5
    ISSN 0031-7144
    ISSN 0031-7144
    DOI 10.1691/ph.2023.3622
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top